Regulation of osteoclastogenesis by mast cell in rheumatoid arthritis
Authors:
Open Access
- 21 April 2021
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 23 (1) , 1-13
Abstract
Background: In the pathogenesis of rheumatoid arthritis (RA), the role of mast cells has not been revealed clearly. We aimed to define the inflammatory and tissue-destructive roles of mast cells in rheumatoid arthritis (RA).Methods: Serum and synovial fluid (SF) concentration levels of tryptase, chymase, and histamine were quantified using ELISA. After activating mast cells using IL-33, the production of TNF-α, IL-1β, IL-6, IL-17, RANKL, and MMPs was determined using real-time PCR and ELISA. Osteoclastogenesis was assessed in CD14+ monocytes from peripheral blood and SF, which were cultured with IL-33-activated mast cells, by counting TRAP-positive multinucleated cells.Results: The concentration levels of serum tryptase, chymase, and histamine and SF histamine were higher in patients with RA than in controls. FcεR1 and c-kit-positive mast cells were higher in RA synovium than in osteoarthritic (OA) synovium. Stimulation of mast cells by IL-33 increased the number of trypatse+chymase− and tryptase+chymase+ mast cells. IL-33 stimulation also increased the gene expression levels of TNF-α, IL-1β, IL-6, IL-17, RANKL, and MMP-9 in mast cells. Furthermore, IL-33 stimulated human CD14+ monocytes to differentiate into TRAP+ multinucleated osteoclasts. When CD14+ monocytes were co-cultured with mast cells, osteoclast differentiation was increased. Additionally, IL-33-activated mast cells stimulated osteoclast differentiation. The inhibition of intercellular contact between mast cells and monocytes using inserts reduced osteoclast differentiation.Conclusions: IL-33 increased inflammatory and tissue-destructive cytokines by activation of mast cells. Mast cells stimulated osteoclast differentiation in monocytes. Mast cells could stimulate osteoclastogenesis indirectly through production of tissue-destructive cytokines and directly through stimulation of osteoclast precursors.Keywords
All Related Versions
Funding Information
- National Research Foundation of Korea (NRF-2018R1D1A1A02050982, NRF-2018R1A2B2006820)
This publication has 41 references indexed in Scilit:
- IL-33 Shifts the Balance from Osteoclast to Alternatively Activated Macrophage Differentiation and Protects from TNF-α–Mediated Bone LossThe Journal of Immunology, 2011
- IL-33: a promising therapeutic target for rheumatoid arthritis?Expert Opinion on Therapeutic Targets, 2011
- Synovial Fibroblasts Promote the Expression and Granule Accumulation of Tryptase via Interleukin-33 and Its Receptor ST-2 (IL1RL1)Journal of Biological Chemistry, 2010
- Interleukin-33 stimulates formation of functional osteoclasts from human CD14+ monocytesCellular and Molecular Life Sciences, 2010
- Mast cell–derived tryptase inhibits apoptosis of human rheumatoid synovial fibroblasts via rho‐mediated signalingArthritis & Rheumatism, 2010
- Histamine index and clinical expression of rheumatoid arthritis activityVojnosanitetski Pregled, 2010
- IL-33 exacerbates antigen-induced arthritis by activating mast cellsProceedings of the National Academy of Sciences, 2008
- Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritisJournal of Experimental Medicine, 2007
- Mast cells in rheumatoid arthritisClinical Rheumatology, 2006
- Effect of IL-13 on cytokines, cytokine receptors and inhibitors on human osteoarthritis synovium and synovial fibroblastsOsteoarthritis and Cartilage, 1998